Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 65776 - 65800 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	VCPKMT	79609	downregulated	resveratrol results in decreased expression of VCPKMT mRNA	14q21.3	A22289
Resveratrol	Investigational	VDR	7421	upregulated	resveratrol results in increased expression of VDR mRNA	12q13.11	A22794 A23859
Resveratrol	Investigational	VEGFA	7422	downregulated	resveratrol results in decreased expression of VEGFA mRNA	6p21.1	A24018 A24019 A23938 A23508 A23962 A23914 A24020 A23883
Resveratrol	Investigational	VEGFA	7422	upregulated	resveratrol results in increased expression of VEGFA mRNA	6p21.1	A22523 A23962
Resveratrol	Investigational	VEGFA	7422	upregulated	[resveratrol results in increased localization of and results in increased activity of CTNNB1 protein] which results in increased expression of VEGFA mRNA	6p21.1	A23962
Resveratrol	Investigational	VEGFB	7423	upregulated	resveratrol results in increased expression of VEGFB mRNA	11q13.1	A24021
Resveratrol	Investigational	VIM	7431	downregulated	resveratrol results in decreased expression of VIM mRNA	10p13	A23897 A23898
Resveratrol	Investigational	VPS13B	157680	downregulated	resveratrol results in decreased expression of VPS13B mRNA	8q22.2	A23852
Resveratrol	Investigational	VSIG2	23584	upregulated	resveratrol results in increased expression of VSIG2 mRNA	11q24.2	A23845
Resveratrol	Investigational	WARS	7453	upregulated	resveratrol results in increased expression of WARS mRNA	14q32.2	A22498 A23847
Resveratrol	Investigational	WASF2	10163	downregulated	resveratrol results in decreased expression of WASF2 mRNA	1p36.11	A23854
Resveratrol	Investigational	WFDC2	10406	upregulated	resveratrol results in increased expression of WFDC2 mRNA	20q13.12	A23908
Resveratrol	Investigational	WNK2	65268	upregulated	resveratrol results in increased expression of WNK2 mRNA	9q22.31	A23852
Resveratrol	Investigational	WNT10A	80326	downregulated	resveratrol results in decreased expression of WNT10A mRNA	2q35	A23893
Resveratrol	Investigational	WNT2	7472	downregulated	resveratrol results in decreased expression of WNT2 mRNA	7q31.2	A23913 A23870
Resveratrol	Investigational	WNT5A	7474	downregulated	resveratrol results in decreased expression of WNT5A mRNA	3p14.3	A23913
Resveratrol	Investigational	WSB1	26118	downregulated	resveratrol results in decreased expression of WSB1 mRNA	17q11.1	A23876
Resveratrol	Investigational	WWP2	11060	downregulated	resveratrol results in decreased expression of WWP2 mRNA	16q22.1	A22289
Resveratrol	Investigational	XIAP	331	upregulated	resveratrol results in increased expression of XIAP mRNA	Xq25	A23872
Resveratrol	Investigational	XRCC1	7515	upregulated	resveratrol results in increased expression of XRCC1 mRNA	19q13.2	A22549
Resveratrol	Investigational	XRCC2	7516	downregulated	resveratrol results in decreased expression of XRCC2 mRNA	7q36.1	A21103
Resveratrol	Investigational	YWHAB	7529	downregulated	resveratrol results in decreased expression of YWHAB mRNA	20q13.12	A21103
Resveratrol	Investigational	YWHAE	7531	downregulated	resveratrol results in decreased expression of YWHAE mRNA	17p13.3	A23847
Resveratrol	Investigational	YWHAE	7531	upregulated	resveratrol results in increased expression of YWHAE mRNA	17p13.3	A21103
Resveratrol	Investigational	YWHAZ	7534	downregulated	resveratrol results in decreased expression of YWHAZ mRNA	8q22.3	A23847

Displaying entries 65776 - 65800 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability